Suboptimum blood pressure is estimated to be the leading risk factor for death worldwide and is associated with 13.5% of deaths globally. The clinical diagnosis of hypertension affects one in four adults globally and is expected to increase by 60% between 2000 and 2025. Clearly, global efforts to prevent and control hypertension are important health issues. While Canada had a prevalence of hypertension similar to that of the United States in the early 1990 s, the treatment and control rate was only 13% compared with 25% in the United States. A national strategic plan was developed, and a coalition of organizations and health care professional and scientist volunteers actively implemented parts of the strategy. Specific initiatives that have evolved include the development of hypertension knowledge translation programs for health professionals, the public and people with hypertension, an outcomes research program to assess the impact of hypertension and guide national-, regional- and community-based knowledge translation interventions, and a program to reduce the prevalence of hypertension by decreasing sodium additives in food. These initiatives have relied on the active involvement of health care professional volunteers, health care professional and scientific organizations and various government departments. There have been large increases in the diagnosis and treatment of hypertension, with corresponding reductions in cardiovascular disease and total mortality associated with the start of the hypertension initiatives. As a result, Canada is becoming recognized as a world leader in the prevention, treatment and control of hypertension.
Notes
Cites: Can J Cardiol. 2000 Sep;16(9):1094-10211021953
Cites: J Hypertens. 2009 Jul;27(7):1472-719474763
Cites: Am J Hypertens. 2001 Nov;14(11 Pt 1):1099-10511724207
Cites: J Hypertens. 2004 Jan;22(1):11-915106785
Cites: JAMA. 1970 Oct 12;214(2):301-105469068
Cites: Public Health Rep. 1987 Sep-Oct;102(5):522-93116583
Cites: JAMA. 1996 May 22-29;275(20):1557-628622246
Cites: Hypertension. 1997 Nov;30(5):1020-49369249
Cites: Am J Hypertens. 2005 Feb;18(2 Pt 1):270-515752956
Cites: Can J Cardiol. 2006 May 15;22(7):556-816755309
Cites: Can J Cardiol. 2006 May 15;22(7):559-6416755310
Cites: Can J Cardiol. 2006 May 15;22(7):599-60316755315